Concepedia

Ashley E. Alarcon-Rozas

AE

Statistics

Publications

2

Citations

103

H-Index

2

Active since

2019

Affiliations

AstraZeneca (United Kingdom)(Current)

Ashley E. Alarcon-Rozas is an author at AstraZeneca (United Kingdom) specializing in medicine, breast cancer oncology, and pi3k inhibitors.

ORCID

Publications per year

2019–2025

2

Publications

2

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population

Nicholas C. Turner, Ashley E. Alarcon-Rozas, Anne Armstrong et al. · Annals of Oncology · 2019 · 89 citations · Full text

, , +16

Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses

Jyoti Mayadev, Juan Carlos Vázquez Limón, Francisco Javier Ramírez Godinez et al. · Annals of Oncology · 2025 · 14 citations · Full text

, , +17

1–2 of 2